Transplanting hepatitis C virus–positive livers into hepatitis C virus–negative patients with preemptive antiviral treatment: A modeling study
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.29723
Abstract: Under current guidelines, hepatitis C virus (HCV)‐positive livers are not transplanted into HCV‐negative recipients because of adverse posttransplant outcomes associated with allograft HCV infection. However, HCV can now be cured post‐LT (liver transplant) using direct‐acting… read more here.
Keywords: negative patients; hcv; hcv negative; hcv positive ... See more keywords
Transplantation of Livers From Viremic Hepatitis C Virus–Positive Donors Into Hepatitis C Virus–Negative Recipients
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30106
Abstract: I have read with interest the paper by Dr. Bari et al. reporting on the use of livers from hepatitis C virus (HCV) antibody–positive, nucleic acid test– negative (nonviremic) donors into HCV negative recipients and… read more here.
Keywords: use; treatment; hcv negative; negative recipients ... See more keywords
Fibrosing cholestatic hepatitis after kidney transplantation from HCV‐viremic donors to HCV‐negative recipients: A unique complication in the DAA era
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Transplantation"
DOI: 10.1111/ajt.15583
Abstract: Fibrosing cholestatic hepatitis (FCH) posttransplantation can lead to graft failure and death. In the era of direct acting antiviral therapy (DAA), several studies have demonstrated the efficacy and safety of transplanting hepatitis C virus (HCV)–positive… read more here.
Keywords: hepatitis; hcv negative; complication; negative recipients ... See more keywords
Cost‐effectiveness of using hepatitis C viremic hearts for transplantation into HCV‐negative recipients
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Transplantation"
DOI: 10.1111/ajt.16245
Abstract: Outcomes following hepatitis C virus (HCV)‐viremic heart transplantation into HCV‐negative recipients with HCV treatment are good. We assessed cost‐effectiveness between cohorts of transplant recipients willing and unwilling to receive HCV‐viremic hearts. Markov model simulated long‐term… read more here.
Keywords: viremic hearts; transplantation hcv; hcv negative; cost ... See more keywords
Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Transplantation"
DOI: 10.12659/aot.933313
Abstract: Background The aim of this study was to evaluate the efficacy and safety of Sofosbuvir/Velpatasvir prophylaxis in hepatitis C virus (HCV)-negative recipients who received a transplant kidney from HCV-infected donors. Material/Methods This retrospective cohort study… read more here.
Keywords: hcv negative; sofosbuvir velpatasvir; negative recipients; transplantation ... See more keywords
The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of cardiothoracic surgery"
DOI: 10.21037/acs.2020.01.03
Abstract: Background There is a low utilization rate of donated donor lungs. Historically, transplantation of lungs from hepatitis C-viremic donors to hepatitis C (HCV) negative recipients was avoided due to concern for worse graft survival. In… read more here.
Keywords: hcv negative; allograft; donor; hcv viremic ... See more keywords
Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Hepatology"
DOI: 10.4254/wjh.v14.i7.1480
Abstract: BACKGROUND The Mac-2 binding protein glycosylation isomer (M2BPGi), a fibrosis marker in various liver diseases, is reportedly a prognostic marker in patients with hepatocellular carcinoma (HCC) who underwent hepatectomy. AIM To evaluate whether the M2BPGi… read more here.
Keywords: hcv negative; pre sarcopenia; early stage;